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Mills DE, Johnson MA, McPhilimey MJ, Williams NC, Gon-
zalez JT, Barnett YA, Sharpe GR. Influence of oxidative stress,
diaphragm fatigue, and inspiratory muscle training on the plasma
cytokine response to maximum sustainable voluntary ventilation. J
Appl Physiol 116: 970–979, 2014. First published February 20, 2014;
doi:10.1152/japplphysiol.01271.2013.—The influence of oxidative
stress, diaphragm fatigue, and inspiratory muscle training (IMT) on
the cytokine response to maximum sustainable voluntary ventilation
(MSVV) is unknown. Twelve healthy males were divided equally into
an IMT or placebo (PLA) group, and before and after a 6-wk
intervention they undertook, on separate days, 1 h of (1) passive rest
and (2) MSVV, whereby participants undertook volitional hyperpnea
at rest that mimicked the breathing and respiratory muscle recruitment
patterns commensurate with heavy cycling exercise. Plasma cytokines
remained unchanged during passive rest. There was a main effect of
time (P  0.01) for plasma interleukin-1 (IL-1) and interleukin-6
(IL-6) concentrations and a strong trend (P  0.067) for plasma
interleukin-1 receptor antagonist concentration during MSVV. Plasma
IL-6 concentration was reduced after IMT by 27  18% (main effect
of intervention, P  0.029), whereas there was no change after PLA
(P  0.753). There was no increase in a systemic marker of oxidative
stress [DNA damage in peripheral blood mononuclear cells (PBMC)],
and diaphragm fatigue was not related to the increases in plasma
IL-1 and IL-6 concentrations. A dose-response relationship was
observed between respiratory muscle work and minute ventilation and
increases in plasma IL-6 concentration. In conclusion, increases in
plasma IL-1 and IL-6 concentrations during MSVV were not due to
diaphragm fatigue or DNA damage in PBMC. Increases in plasma
IL-6 concentration during MSVV are attenuated following IMT, and
the plasma IL-6 response is dependent upon the level of respiratory
muscle work and minute ventilation.
cytokine; respiratory muscles; ventilation
WE RECENTLY DEMONSTRATED THAT plasma interleukin-6 (IL-6)
concentration increased when young, healthy adults undertook
1 h of volitional hyperpnea at rest that mimicked the breathing
and respiratory muscle recruitment patterns commensurate
with cycling exercise undertaken at an estimated maximum
lactate steady-state intensity (42). This finding supports the
notion that the respiratory muscles may contribute to systemic
increases in plasma IL-6 concentration observed when the
intensity of respiratory muscle work is increased such as in
strenuous whole-body exercise, asthma attacks, and exacerba-
tions of chronic obstructive pulmonary disease (COPD) (34,
48, 71).
We also demonstrated that volitional hyperpnea elevated
plasma IL-6 concentrations in the absence of diaphragm fa-
tigue, and that inspiratory muscle training (IMT) reduced the
plasma IL-6 response to exercise but not volitional hyperpnea
(42). Whether other plasma cytokines may be affected by such
interventions is unknown. Whole-body exercise and inspira-
tory resistive loading (IRL) can increase the plasma concen-
tration of the proinflammatory cytokine interleukin-1 (IL-1)
and IL-6 (45, 66, 67). Within the diaphragm of rats exposed to
IRL, IL-1 and IL-6 are stimulated by oxidative stress and
possibly diaphragm fatigue (56, 57, 65).
IL-1 can impair striated muscle function and potentially
reduce muscle contractility (37). IL-1 may also have a role
within muscle repair and regeneration following injury. The
IL-1 gene is activated with strenuous muscular contraction,
and the associated micro injury that occurs within the muscle
stimulates quiescent resident macrophages to secrete IL-1
(11, 17, 21, 51, 64). IL-1 also stimulates proteolysis and acts
a chemoattractant for macrophages which can phagocytize
cellular debris and provide a large source of growth factors
which may stimulate myogenesis (11, 17, 21, 51, 64). There-
fore, oxidative stress, respiratory muscle fatigue/injury, and
repair/regeneration may be stimuli for the production of IL-1
by human respiratory muscles. In addition, since respiratory
muscle training attenuates exercise-induced diaphragm fatigue
during whole-body exercise (68), IMT may also reduce IL-1
production by the inspiratory muscles.
Whole-body exercise also increases the plasma concentra-
tion of the anti-inflammatory cytokine interleukin-1 receptor
antagonist (IL-1ra) (45, 54, 72). IL-1ra is stimulated by IL-6
and IL-1 and acts to restrict and limit the extent of the
inflammatory response by inhibiting signaling transduction of
interleukin-1 through the interleukin-1 receptor complex (18,
62). Recent evidence has demonstrated that the plasma IL-1ra
response to exercise is attenuated following whole-body en-
durance training (72). This may be due to a training-induced
reduction in IL-6 and/or IL- which may also occur following
IMT.
The maximum lactate steady state represents the highest
work rate at which a physiological steady state can be achieved
and, therefore, marks the boundary between sustainable and
nonsustainable work rates (30, 31). The minute ventilation
(V˙ E) associated with the maximum lactate steady state is
known to be well below an individual’s maximum sustainable
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voluntary ventilation (MSVV) (31) and, therefore, our previ-
ously reported breathing-induced plasma IL-6 response may
have been submaximal (42). The notion that inflammatory
responses to respiratory muscle work and V˙ E may be dose
dependent is supported by the observation that increases in
plasma IL-6 concentration are intensity dependent during
whole-body exercise (47, 54). Therefore, an aim of this study
was to examine the response of plasma cytokines IL-1,
IL-1ra, and IL-6 to MSVV, whereby participants undertook
volitional hyperpnea at rest that mimicked the breathing and
respiratory muscle recruitment patterns commensurate with
heavy cycling exercise. We also sought to examine the mech-
anism(s) for cytokine production by measuring diaphragm
fatigue [known to be elicited by MSVV (3)] and a systemic
marker of oxidative stress. Finally, we examined whether these
responses were altered by IMT.
METHODS
Participants. Twelve nonsmoking recreationally active males pro-
vided written, informed consent to participate in the study which was
approved by the Nottingham Trent University Human Ethics Com-
mittee. The characteristics, pulmonary function, maximal inspiratory
pressure (MIP), maximum power output, and peak oxygen uptake of
the study participants has been described previously (42). A self-
reported medical questionnaire confirmed that participants were free
from illness and injury and not taking any medication and/or antiox-
idant supplements during the study. Each participant completed a 24-h
diet record prior to their first trial, which was then replicated prior to
all subsequent trials. Throughout the study, participants were in-
structed to adhere to their habitual training regimen and not to engage
in any strenuous exercise the day preceding, the day of, and in the 24
h following each trial. Participants arrived at the laboratory 4 h
postprandially having abstained from alcohol and caffeine in the 24 h
before testing.
Experimental design. Participants attended the laboratory on three
separate occasions, before and after a 6-wk intervention (Fig. 1). Each
laboratory visit was separated by 48 h and took place at the same time
of day. During the first visit, participants were familiarized with all
testing procedures and pulmonary function, and MIP were measured.
During the second visit, participants performed a maximal incremen-
tal cycling test. The subsequent two experimental trials were random-
ized, lasted 1 h and comprised (1) passive rest (PASSIVE) and (2)
MSVV. Thereafter, participants were randomly, and equally, divided
into an IMT or placebo (PLA) group and completed the intervention.
At least 48-h postintervention, participants repeated the maximal
incremental cycling test and experimental trials in the same order as
preintervention. All trials were performed on an electromagnetically
braked cycle ergometer (Excalibur Sport, Lode, Groningen, The
Netherlands).
Pulmonary function and maximal inspiratory mouth pressure.
Pulmonary function was assessed according to published guidelines
(41) using a pneumotachograph (Pneumotrac, Vitalograph, Bucking-
ham, UK) calibrated with a 3-l syringe. A hand-held mouth pressure
meter (MicroRPM, CareFusion, Basingstoke, UK) measured MIP as
an index of global inspiratory muscle strength. The mouthpiece
assembly incorporated a 1-mm orifice to prevent glottic closure during
inspiratory efforts. Maneuvers were performed while standing, initi-
ated from residual volume, and sustained for at least 1 s. Repeat
efforts separated by 30 s were performed until three serial measures
differed by no more than 10% or 10 cmH2O, whichever was smallest
(8, 10, 28). The highest value recorded was used for subsequent
analysis.
Maximum incremental cycling test. Cycling began at 0 W, and
power was subsequently increased by 10 W every 15 s in order to
result in exercise intolerance within 10 min. This rapid incremental
protocol was selected to maximize V˙ E at the cessation of the test and,
therefore, reflect heavy exercise. The power at which exercise intol-
erance ensued defined maximum power output, and the highest V˙ E
and oxygen uptake recorded in any 30 s period defined peak V˙ E
(V˙ Epeak) and peak oxygen uptake, respectively.
Fig. 1. Schematic of experimental design.
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Experimental trials. During experimental trials, the configuration
of the cycle ergometer and the body position adopted by each
participant were identical to those adopted during the maximal incre-
mental cycling test. MSVV was preceded by a 5-min rest period, and
during PASSIVE participants remained seated on the cycle ergometer
for the duration of the trial. During MSVV participants undertook
volitional hyperpnea at rest that mimicked the breathing [tidal volume
(VT); breathing frequency (fB); and duty cycle (TI/TTOT)] and respi-
ratory muscle recruitment [peak transdiaphragmatic pressure (Pdipeak)]
patterns commensurate with heavy cycling exercise. These variables
were determined from the average values obtained between 70–80%
of the V˙ Epeak attained during the preintervention maximal incremental
cycling test; pilot work showed that this represented the maximum
voluntary ventilation that could be sustained for 1 h. During the
postintervention MSVV trial, participants mimicked the breathing and
respiratory muscle recruitment patterns performed during the prein-
tervention MSVV trial. An audio metronome paced fB and TI/TTOT,
and real-time visual feedback of VT and Pdipeak was provided through-
out. The use of Pdipeak targets allowed us to more precisely control the
mechanical work of breathing during MSVV (3, 35). All experimental
trials were performed in an environmental chamber (Design Environ-
mental WIR52-20HS, Design Environmental, Ebbw Vale, UK) at
20°C and 90% relative humidity to minimize mucosal drying during
MSVV (42).
Flow, pulmonary gas exchange, and pressure measurements. Dur-
ing all trials participants wore a facemask (model 7940, Hans Ru-
dolph, Kansas City, MO) connected to a flow sensor (ZAN variable
orifice pneumotach, Nspire Health, Oberthulba, Germany) that was
calibrated using a 3-l syringe. Gas concentrations were measured
using fast responding laser diode absorption spectroscopy sensors,
which were calibrated using gases of known (5% CO2, 15% O2 and
balance N2) concentrations (BOC, Guildford, UK), and ventilatory
and pulmonary gas exchange variables were determined breath-by-
breath (ZAN 600USB, Nspire Health). During experimental trials a
two-way nonrebreathing valve (model 2730, Hans Rudolph) was
attached distally to the pneumotachograph, and a 1.5-m length of
wide-bore tubing was connected to the inspiratory port. During
MSVV, CO2 was added into this tubing to increase FICO2 and thus
retain end-tidal and, consequently, blood PCO2 at levels commensurate
with rest (9, 31). On the expiratory port of the two-way valve a Fleisch
no. 3 pneumotachograph was attached and connected to a differential
pressure transducer ( 2.5 cmH2O) (TSD160A, BIOPAC Systems,
Goleta, CA) and differential bridge amplifier (DA100C, BIOPAC
Systems) to allow alignment of flow and pressure signals. Esophageal
(Pe) and gastric (Pga) pressures were measured and calibrated as
described previously (42). Transdiaphragmatic pressure (Pdi) was
calculated by subtracting Pe from Pga. As an estimate of respiratory
muscle work, Pdi and Pe were integrated over the period of inspiratory
flow and multiplied by fB and labeled the diaphragm pressure-time
product (PTPdi) and the inspiratory muscle pressure-time product
(PTPe), respectively. Nonphysiological flows and pressures that re-
sulted from swallowing, coughing, and breath holding were identified
by visual inspection and removed. Breathing mechanics data were
ensemble averaged into six 10-min blocks and used for subsequent
analysis.
Bilateral anterior magnetic phrenic nerve stimulation. Bilateral
anterior magnetic phrenic nerve stimulation (BAMPS) (43) was ap-
plied using two double 25-mm coils connected to two Magstim 2002
stimulators (Magstim, Whitland, UK) as described previously (42). To
determine supramaximal phrenic nerve stimulation, three single
twitches were obtained every 30 s at intensities of 50, 60, 70, 80, 85,
90, 95, and 100% of maximal stimulator output. A plateau in trans-
diaphragmatic twitch pressure (Pditw) and M-wave responses with
increasing stimulation intensities indicated maximum depolarization
of the phrenic nerves. Pditw was assessed every 30 s using eight single
stimuli at 100% of maximal stimulator output. Pditw was measured at
baseline and within 15 (15 min), 35 (35 min), and 60 (60 min)
min after each experimental trial. Additionally, Pditw at each measure-
ment point was followed by the assessment of the potentiated Pditw
response. Participants performed a 3-s maximal Müeller maneuver
and 5 s later a single stimuli was delivered. This procedure was
repeated six times with each measure separated by 30 s. The average
of the median three individual Pditw responses were used for analysis.
Diaphragm fatigue was defined as a 15% reduction in Pditw com-
pared with the baseline value (36, 42).
Measurement of systemic oxidative stress. Arterialized venous
blood was sampled from a dorsal hand vein via an indwelling 21-G
cannula (40). Arterialization was ensured by immersing the hand in
water at 40°C for 10 min prior to cannulation and by warming the
hand during trials using an infrared lamp. Levels of systemic oxidative
stress were determined using the Comet Assay, which can measure
oxidative DNA damage in peripheral blood mononuclear cells
(PBMC). Previously, data has reported an increase in systemic DNA
damage following heavy cycling exercise using the Comet Assay (49,
69). During the experimental trials, 5-ml blood samples were taken at
rest, immediately following the experimental trial (0 h) and 1 day into
recovery (24 h). Blood was immediately transferred into precooled
tubes containing lithium heparin (SARSTEDT, Leicester, UK).
PBMC were isolated using density gradient centrifugation. The hep-
arinized venous blood was mixed with 5 ml of phosphate buffered
saline and layered onto a lymphocyte separation medium (Ficoll-
Paque Plus, Griener Bio-One, Stonehouse, UK) inside a Leucosep
tube (Griener Bio-One) and centrifuged for 15 min at 800 g and room
temperature. The opaque mononuclear cell layer was aspirated and
washed 3 times in phosphate buffered saline and centrifuged for 10
min at 200 g and room temperature. The cells were cryopreserved in
liquid nitrogen for subsequent analysis in a medium consisting of 10%
Dimethyl sulfoxide (Sigma-Aldrich, Gillingham, UK), 20% fetal
bovine serum (Invitrogen, Paisley, UK) and 70% X-Vivo 10 media
(Lonza, Wokingham, UK).
Levels of DNA damage (DNA single-strand breaks and alkali
labile lesions) in PBMC were determined in duplicate using the
alkaline Comet Assay (59) and the modified alkaline Comet Assay
(15) as described by Marthandan et al. (38). In the modified Comet
Assay, PBMC embedded on slides were treated with either formami-
dopyrimidineglycosylase (FPG) which recognizes oxidatively modi-
fied purines (6), or with endonuclease III (ENDO III) which recog-
nizes oxidatively modified pyrimidines (2). These enzymes nick DNA
at the sites of oxidatively damaged nucleotides, creating single-strand
breaks which can be detected with the alkaline Comet Assay. PBMC
treated with 150 	M of hydrogen peroxide for 5 min at 4°C (to induce
oxidative damage) were used as internal positive controls in the
modified alkaline Comet Assay.
The Comet Assays were performed at 4°C to minimize the repair of
existing basal levels of DNA damage present in PBMC. PBMC (2 

104 cells/gel) were embedded in a 1% agarose gel on frosted micro-
scope slides and lysed for 1 h in a high salt alkaline buffer [2.5 M
sodium chloride, 0.1 M EDTA, 0.01 M Tris, 1% (v/v), Triton X-100,
pH 10]. For the modified Comet Assays, slides were equilibrated in
enzyme buffer (0.04 M HEPES, 0.1 M potassium chloride, 0.5 mM
EDTA, 0.2 mg/ml bovine serum albumin, pH 8.0) prior to the
application of FPG or ENDO III. Slides treated with the lesion specific
enzymes were incubated at 37°C in a humid, dark chamber for 45 min.
Following enzyme treatment (or immediately after alkaline lysis for
the alkaline Comet Assay), the slides were placed in electrophoresis
buffer (0.3 M sodium hydroxide, 1 mM EDTA, pH 13) for 20 min, to
allow alkaline unwinding of the DNA, and then electrophoresed at 25
V and 300 mA for 30 min. Subsequently, slides were neutralized (0.4
M Tris, pH 7.5) and stained (50 	g/ml ethidium bromide) to visualize
DNA. Stained slides were digitally analyzed using ultraviolet micros-
copy (Carl Zeiss, Welwyn Garden City, UK) and scored (50 PBMC
per slide) using analysis software (Komet 5.5, Andor Bio Imaging,
Nottingham, UK) by the same investigator. The interassay coefficient
of variation (CV) was 10%.
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Cytokines and additional blood analyses and measurements. At
rest, immediately after (0 h) and 1 (1 h), 2 (2 h), and 24 (24 h)
h after each experimental trial, 3
 5 ml blood samples were taken for
the measurement of plasma IL-1, IL-1ra, and IL-6 concentrations.
Blood was transferred into precooled tubes containing 1.6 mg/ml of
K3E EDTA (SARSTEDT) and immediately centrifuged for 15 min at
1,000 g and 5°C. The plasma supernatant was subsequently removed
and stored at 80°C until further analysis. Commercial solid phase
sandwich ELISA were used to measure plasma concentrations of
IL-1, IL-6 (Quantikine HS, R&D Systems Abingdon, UK), and
IL-1ra (Quantikine, R&D Systems) in duplicate. The assays have a
detection limit of 0.1 pg/ml (IL-1), 22 pg/ml (IL-1ra), and 0.039
pg/ml (IL-6), respectively. To minimize the effect of interassay
variation, pre- and postintervention cytokines from both groups were
measured during the same assay. The inter- and intra-assay CV for
ELISA were 10%.
During the experimental trials, blood samples were taken at rest,
every 3 min for the initial 15 min, and every 5 min thereafter and
analyzed immediately for PCO2 and pH (ABL520, Radiometer, Co-
penhagen, Denmark), which were corrected for changes in rectal
temperature (Squirrel 2020, Grant Instruments, Cambridge, UK). At
rest and every 10 min during each trial blood lactate concentration
([La]B) was determined using an automated analyzer (Biosen C-line
Sport, EKF Diagnostics, Barleben, Germany), and measurements
were taken for cardiac frequency (fC) using short-range telemetry
(Polar S610, Polar, Kempele, Finland), estimated arterial oxygen
saturation (SpO2) using infrared fingertip pulse oximetry (Model
8600, Nonin, Plymouth, MN), and dyspnea using Borg’s modified
CR10 rating of perceived exertion scale (7).
Inspiratory muscle training and placebo interventions. The inter-
vention lasted 6 wk. The IMT group performed 30 consecutive
dynamic inspiratory efforts twice daily using an inspiratory pressure-
threshold device (POWERbreathe Classic series 1st generation, Ga-
iam, Southam, UK). The initial training load was 50% MIP. There-
after, participants periodically increased the load so that 30 maneuvers
could only just be completed. Each inspiratory effort was initiated
from residual volume and participants strove to maximize VT. This
regimen is known to be effective in eliciting an adaptive response (29,
42, 52). The PLA group inhaled one puff twice daily from a sham
metered dose inhaler (Vitalograph) (42). The inhaler contained com-
pressed air only but was promoted to the participants as delivering a
novel drug that reduces breathing-induced inflammation. During the
postintervention period, the IMT and PLA groups performed their
intervention 2 d/wk, which is sufficient to maintain improvements in
inspiratory muscle function following IMT (52). These maintenance
sessions were performed 48 h before and 48 h after experimental
trials. All participants completed a training diary throughout the study
to record adherence to the prescribed intervention and whole-body
training sessions.
Statistical analyses. Statistical analyses were performed using
SPSS for Windows (IBM, Chicago, IL). Normality of the data was
assessed by visual inspection of histograms. In addition, skewness and
kurtosis scores were converted to Z-scores by dividing them by their
standard error. Resulting scores greater than 1.96 were considered to
be significant. The majority (90%) of the data were normally
distributed. Therefore, the data were not log-transformed and para-
metric statistics were used. Between- and within-group comparisons/
changes in baseline characteristics, including pulmonary function and
MIP, were made using independent and paired t-tests, respectively. A
three-way ANOVA was used to analyze the effects of “intervention”
(pre- vs. post-“treatment”) and “time” (10, 20, 30, 40, 50 and 60 min
for breathing and respiratory muscle recruitment pattern and dyspnea
data; rest 10, 20, 30, 40, 50, and 60 min for [La]B, pH, PCO2, fC, and
SpO2 data; rest, 0, and 24 h for DNA damage data; rest, 0, 1, 2,
and 24 h for plasma cytokine data; or baseline, 15, 35, and 60
min for Pditw data) with a between-subject factor of treatment (IMT
vs. PLA). Intervention 
 treatment interaction effects and within-
group changes were further explored by analyzing IMT and PLA
groups separately using two-way repeated-measures ANOVA. Distri-
bution and variance homogeneity of the residuals from the ANOVA
were evaluated using probability plots. Planned pairwise comparisons
were made with paired repeated-measures t-tests with Bonferroni
adjustment. Reliability was assessed using a CV calculated from a
pooled mean of both groups and all trials. Statistical significance was
set at P  0.05. Results are presented as means  SD.
RESULTS
Age (IMT vs. PLA: 27  7 vs. 22  3 yr), body mass (80 
6 vs. 74  7 kg), height (181  5 vs. 177  4 cm), and peak
oxygen uptake (52  6.2 vs. 47  5.7 ml·kg1·min1) were
not different between groups. Maximum power output (378 
21 vs. 336  23 W) and V˙ Epeak (154  19 vs. 120  27 l/min)
were higher (P  0.05) for the IMT group. All other preinter-
vention measurements were not different between groups. All
responses remained unchanged from rest during PASSIVE
trials (data not shown).
Pulmonary function and maximal inspiratory pressure. Pre-
intervention pulmonary function (data not shown) and MIP
were within normal limits. Compliance with the intervention
was excellent in both IMT and PLA groups with 96 1 and 93
1% of sessions completed, respectively. Pulmonary function
was unchanged in both groups postintervention, whereas MIP
increased from 168  49 to 202  39 cmH2O (24  16%)
after IMT (P  0.01). Inspection of training diaries revealed
habitual whole-body training remained constant in both
groups.
Breathing and respiratory muscle recruitment patterns.
There were no main effects of intervention for breathing and
respiratory muscle recruitment pattern data during MSVV
(Table 1 and Fig. 2). This shows that participants were able to
accurately mimic the breathing and respiratory muscle recruit-
ment patterns commensurate with heavy cycling exercise and
that these factors were the same before and after IMT and PLA.
The intertrial CV for Pdipeak at rest was 7%.
Plasma cytokine concentrations. There was a main effect of
time (P  0.01) for plasma IL-1 and IL-6 concentrations and
a strong trend (P  0.067) for plasma IL-1ra concentration
during MSVV (Fig. 3). There were no other main or interaction
effects for plasma IL-1 and IL-ra concentrations, whereas
there was a main effect for intervention (P  0.048) and
intervention 
 treatment (P  0.025) and intervention 
 time 

treatment (P  0.024) interactions for plasma IL-6 concentra-
tion (Fig. 3). To explore the nature of these interactions, a
subsequent two-way ANOVA performed separately for IMT
and PLA groups revealed that plasma IL-6 concentration was
reduced after IMT (main effect of intervention, P  0.029),
whereas there was no change after PLA (P  0.753).
DNA damage in PBMC. Preintervention alkaline, FPG and
ENDO III Comets at rest during MSVV were 9.2  4.6,
15.6  6.3, and 13.4  5.5%DNA in Comet tail for the IMT
group and 8.2  3.3, 17.8  7.3, and 10.8  2.0%DNA in
Comet tail for the PLA group. There were no main or interac-
tion effects demonstrating that MSVV did not induce DNA
damage in PBMC.
Twitch transdiaphragmatic pressures. A plateau (i.e., no
significant increase in amplitude with increasing stimulation
intensity) in Pditw and M-wave amplitude (data not shown) was
observed in response to supramaximal BAMPS, indicating
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maximal depolarization of the phrenic nerves. There were no
main or interaction effects for nonpotentiated Pditw during
MSVV (data not shown). There was a main effect of time (P
0.01) for potentiated Pditw, demonstrating evidence of dia-
phragm fatigue, but there were no other main or interaction
effects (Fig. 4). Compared with baseline measures, preinter-
vention potentiated Pditw was reduced by 15 and 20% at 15
min for IMT and PLA groups, respectively. The inter- and
intratrial CV for baseline nonpotentiated Pditw and potentiated
Pditw was 8%.
Additional measurements. There were no main effects of
time for pH, PCO2, and SaO2, showing that these variables were
maintained at rest during MSVV (Table 1). There were main
effects of time (P  0.01) for [La]B, fC and dyspnea during
MSVV (Table 1). There were no other main or interaction
effects for [La]B or fC, whereas there were main effects of
intervention (P  0.034) and intervention 
 treatment (P 
0.011) and intervention 
 time 
 treatment (P  0.007)
interactions for dyspnea during MSVV (Table 1). To explore
the nature of these interactions, a subsequent two-way
ANOVA performed separately for IMT and PLA groups re-
vealed that dyspnea was reduced after IMT (main effect of
intervention, P  0.018), whereas there was no change after
PLA (P  0.617).
Correlations among plasma IL-1 and IL-6 increases and
selected variables during MSVV. There was a moderate nega-
tive correlation between the peak percentage increase from
resting values in plasma IL-1 concentration and mean per-
centage of V˙ Epeak achieved during the preintervention maximal
incremental cycling test (%V˙ Epeak) (r  0.68, P  0.016)
during MSVV. There were moderate to strong positive corre-
lations between the peak percentage increase from resting
values in plasma IL-6 concentration and mean V˙ E (r  0.74,
P  0.006) and %V˙ Epeak (r  0.63, P  0.029) during MSVV.
There were no correlations between the peak percentage in-
crease from rest in each plasma cytokine and the reduction in
Pditw following MSVV.
Dose-response relationship of plasma interleukin-6 con-
centration. We have also attempted to quantify the dose-
response relationship between the plasma IL-6 response and
respiratory muscle work and V˙ E. Figure 5 combines the pre-
intervention IL-6 responses from the present study with those
measured in our previous study (42) (12 participants from IMT
and PLA groups, 2 volitional hyperpnea trials, 24 observations)
and shows moderate to strong positive correlations between the
peak percentage increase from rest in plasma IL-6 concentra-
tion and mean PTPdi, PTPe, and V˙ E during 1 h of steady state
(42) and maximal sustainable (present study) voluntary venti-
lation.
DISCUSSION
Main findings. The main findings of this study were that
following MSVV, whereby participants undertook 1 h of
volitional hyperpnea at rest that mimicked the breathing and
respiratory muscle recruitment patterns commensurate with
heavy cycling exercise, plasma IL-1 and IL-6 concentrations
were significantly increased and there was a strong trend for an
increase in plasma IL-1ra concentration. The plasma IL-6
response was attenuated following IMT, whereas the plasma
IL-1 response was unchanged. The mechanisms responsible
for the increase in plasma IL-1 and IL-6 concentration could
not be fully established as 1) there was no increase in a
systemic marker of oxidative stress (DNA damage in PBMC),
and 2) although diaphragm fatigue was evident following
MSVV, it was not related to the increase in plasma IL-1 and
IL-6 concentrations. Finally, a dose-response relationship be-
tween the plasma IL-6 response and respiratory muscle work
and V˙ E was established.
To our knowledge, we are the first to report the plasma
IL-1, IL-1ra, and IL-6 response to MSVV. The increase in
plasma IL-1 concentration following MSVV was of a similar
magnitude to that reported following IRL at 75% MIP until
task failure (66, 67), whereas the increase in plasma IL-6
concentration following MSVV was much greater. We are
confident that the increases in plasma IL-1 and IL-6 concen-
tration observed during MSVV are not an artefact of the
experimental conditions since plasma cytokine concentrations
were unchanged during the PASSIVE trial.
Stimuli for interleukin-1 and interleukin-6. The lack of
DNA damage in PBMC following MSVV suggests that sys-
temic oxidative stress was not responsible for the increase in
plasma IL- and IL-6 concentrations following MSVV. How-
ever, it cannot be excluded that there was a local increase
Table 1. Physiological responses and dyspnea during maximum sustainable voluntary ventilation for inspiratory muscle
training (IMT) and placebo (PLA) groups
IMT PLA
Preintervention Postintervention Preintervention Postintervention
V˙ E, l/min 109  20 109  15 99  19 98  19
%V˙ Epeak, % 71  12 71  9 82  20 82  6
VT, l 2.75  0.68 2.71 0.68 2.70  0.43 2.66  0.41
fB, breaths/min 42  10 42  10 37  6 37  6
TI/TTOT 0.49  0.04 0.48 0.05 0.50  0.03 0.50  0.02
[La]B, mmol/l 1.37  0.57 1.21 0.40 1.29  0.41 1.19  0.48
pH 7.399  0.042 7.409 0.034 7.407  0.027 7.408  0.032
PCO2, mmHg 44.4  4.4 43.8 4.3 41.3  3.9 41.8  4.3
fC, beats/min 84  9 80  10 74  6 74  13
SpO2, % 99  1 99  1 99  1 99  1
Dyspnea 5.4 2.8 2.8  1.0 3.9  2.4 4.2  3.0
V˙ E, minute ventilation; %V˙ Epeak, percentage of peak minute ventilation achieved during the preintervention maximal incremental cycling test; VT, tidal
volume; fB, breathing frequency; TI/TTOT, duty cycle; [La]B, blood lactate concentration; PCO2, partial pressure carbon dioxide; fC, cardiac frequency; SpO2,
arterial oxygen saturation. See text for description of analyses.
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within the respiratory muscles. Oxidative stress due to en-
hanced generation of reactive oxygen and nitrogen species is
an important regulator of IL-1 and IL-6 production. Reactive
oxygen species can upregulate IL-1 and IL-6 in the dia-
phragm of rats exposed to IRL (57). It could also be speculated
that any localized increase in oxidative stress that might have
occurred during MSVV was not sufficient to cause systemic
DNA damage in PBMC. Lastly, we acknowledge that no single
measurement of oxidative stress will summarize all the effects
of MSVV and an effect may only be evident with a battery of
markers (46).
As expected, there was evidence of diaphragm fatigue
following MSVV. However, diaphragm fatigue does not
seem to be mechanistically linked with the increase in
plasma IL-1 and IL-6 concentrations. This view is sup-
ported by the observations that the extent of diaphragm
fatigue was not correlated with the magnitude of the plasma
IL-1 and IL-6 concentration increase following MSVV,
and that the extent of diaphragm fatigue remained remark-
ably consistent after IMT while the plasma IL-6 response
was reduced. Confidence in our data is supported by the
demonstration of supramaximal stimulation in Pditw and
M-wave responses and excellent inter- and intratrial reli-
ability in Pditw. Therefore, our data do not support the notion
(66, 67) that diaphragm fatigue triggers IL-1 and IL-6
release.
Fig. 2. The relative contribution of dia-
phragm to the inspiratory muscle pressure-
time product (PTPdi/PTPe) (A), diaphragm
pressure-time product (PTPdi) (B), inspira-
tory muscle pressure-time product (PTPe)
(C), and peak transdiaphragmatic pressure
(Pdipeak) (D) during maximum sustainable
voluntary ventilation (MSVV) for inspira-
tory muscle training (IMT) and placebo
(PLA) groups. Values are means  SD.
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A more likely mechanism for the production of IL-6 may be
a reduction in respiratory muscle glycogen content. Muscle
glycogen depletion during prolonged and strenuous lower-
body exercise is a strong stimulus for enhanced IL-6 produc-
tion by skeletal muscle fibers (32, 61). This notion is supported
by the reduced diaphragm glycogen content of murines ex-
posed to IRL (14) and whole-body exercise (23, 26).
Source of plasma interleukin-1 and interleukin-6. Con-
tracting skeletal muscle accounts for most (but not all) of the
increase in plasma IL-6 concentration observed during lower-
body exercise (63). Thus although our experimental model did
not allow the source(s) of the increased plasma IL-1 and IL-6
following MSVV to be established, we attribute this increase
to, primarily, increased IL-1 and IL-6 release from contract-
Fig. 3. Plasma interleukin-1 receptor antag-
onist (IL-1ra) (A), interleukin-1 (IL-1)
(B), and interleukin-6 (IL-6) (C) concentra-
tions during MSVV for IMT and PLA
groups. Significant difference from rest
(*P  0.05; **P  0.01) and from the
preintervention measurement at the same
time point for the IMT group (†P  0.05;
††P  0.01). Values are means  SD.
Fig. 4. Potentiated transdiaphragmatic twitch
pressure (Pditw) during MSVV for IMT and
PLA groups. Significant difference from base-
line (**P  0.01). Values are means  SD.
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ing respiratory muscles. This notion is consistent with the
increased IL-1 and IL-6 mRNA and protein expression in the
diaphragm of rats exposed to IRL (56, 57, 65) and the higher
IL-1 and IL-6 protein expression in the external intercostals
of patients with COPD compared with healthy controls (13).
Role of plasma interleukin-1 and interleukin-6. IL-1 may
have a role within muscle repair and regeneration following
injury. The IL-1 gene is activated with strenuous muscular
contraction and the associated micro injury that occurs within
the muscle stimulates quiescent resident macrophages to se-
crete IL-1 (11, 17, 21, 51, 64). IL-1 also stimulates prote-
olysis and acts as a chemoattractant for macrophages which
can phagocytize cellular debris and provide a large source of
growth factors which may stimulate myogenesis (11, 17, 21,
51, 64). IL-1 can also impair striated muscle function and
potentially reduce muscle contractility (37). IL-6 acts to stim-
ulate lipolysis (67), hepatic glucose output (20), and glucose
uptake in the contracting myocytes (10). IL-6 may also con-
tribute to muscle repair and regeneration after injury which
may involve a stimulatory effect on satellite cell proliferation
(33, 64).
Effects of inspiratory muscle training on plasma interleu-
kin-6 concentration. The present study is the first to demon-
strate an attenuated plasma IL-6 response to MSVV following
IMT. Reduced IL-6 production by inspiratory muscles follow-
ing IMT may result from increases in basal levels of IL-6
receptor  (1, 32) or antioxidant enzymes (72), or reduced
muscle glycogen utilization (16, 22) secondary to training-
induced increases in mitochondrial density (25). In our previ-
ous study, IMT did not attenuate the plasma IL-6 response to
volitional hyperpnea that mimicked at rest the breathing and
respiratory muscle recruitment patterns commensurate with
cycling exercise undertaken at an estimated maximum lactate
steady-state intensity (42). This suggests that there may be a
threshold of ventilatory work above which respiratory muscle
glycogen is significantly reduced and an effect of IMT on
plasma IL-6 concentration is observed. Respiratory muscle
metaboreflex activation (55, 60) may be attenuated by IMT
(39, 70), thus promoting increased blood flow to the liver (20)
and/or leg muscles (39). This may increase hepatosplanchnic
uptake of IL-6 (20), whereas increased leg blood flow may
result in less muscle glycogen utilization due to increased
oxygen (4) and/or glucose (19) delivery. However, since the
extent of diaphragm fatigue after MSVV was unchanged by
IMT, leg muscles were inactive, and liver blood flow was
unlikely to be affected by MSVV (during which cardiac output
was presumably well below maximal), we feel that this expla-
nation for reduced plasma IL-6 concentration is unlikely.
Dose-response relationship of plasma interleukin-6 con-
centration. We are the first to report a dose-response relation-
ship between the plasma IL-6 response and respiratory muscle
work and V˙ E. These findings are broadly in line with the
observation that increases in plasma IL-6 concentration are
intensity dependent during whole-body exercise (47, 54). The
dose-response may be explained by increased stimuli for IL-6
production such as greater oxidative stress or reductions in
muscle glycogen content. Alternatively, increased IL-6 produc-
tion may be attributed to the less efficient accessory inspiratory
(and expiratory) muscles. The relative contribution of these
muscles progressively increases (as the contribution from the
diaphragm decreases) when ventilatory work rises (27, 53).
When expressed relative to the size of the muscle group used,
the arm muscles release greater amounts of IL-6 than leg
muscles and this is not directly related to release or uptake of
exogenous substrate or muscle glycogen utilization (24) but
may be due to differences in fiber type composition and
vascular supply. In humans, the ratio of slow twitch fibers and
number of capillaries per fiber are 50% and 1.9 for the
diaphragm, and 60% and 1.6 for the internal intercostals (44).
Therefore, the less efficient accessory inspiratory muscles may
also produce more IL-6 (relative to size) than the diaphragm
due to differences in fiber type composition and vascular
supply.
Application to asthma and COPD. Asthma attacks and
COPD exacerbations lead to systemic inflammation due to
inflammatory cytokines. The local source of these cytokines is
not, however, fully understood. Some suggest that cytokines
spill out from the lungs into the systemic circulation, whereas
others suggest that multiple organs contribute (34, 58, 71).
Consistent with previous studies (12, 13, 66, 67) our data
Fig. 5. Correlations between plasma interleukin-6 (IL-6) concentration and respiratory muscle work and minute ventilation (V˙ E). The regression lines are for
group mean data. The correlation coefficients (r) and associated P values are for repeated observations within participants (5) where plasma IL-6 concentration
(peak percentage increase from resting values) was treated as the dependent variable and the mean diaphragm pressure-time product (PTPdi) (A), inspiratory
muscle pressure-time product (PTPe) (B), and V˙ E (C) during 1 h of steady state (42) and maximal sustainable (present study) voluntary ventilation are treated
as the independent variables, and participant treated as the categorical variable.
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suggest that the respiratory muscles directly contribute to the
systemic inflammation observed in these patients when respi-
ratory muscle work is increased. Systemic inflammation in
patients with asthma and COPD can contribute to increased
mortality and reduced exercise capacity, health status, and
quality of life (34, 71). However, based on the findings of the
present study, it is attractive to speculate that IMT may reduce
the plasma IL-6 response during periods of increased respira-
tory muscle work in patients with asthma and COPD. Respi-
ratory muscle–derived cytokines in patients with severe COPD
might impair muscle function and potentially reduce muscle
contractility, while also playing a role in muscle repair/regen-
eration (50).
Conclusion. In conclusion, following MSVV plasma IL-1
and IL-6 concentrations were significantly increased, and there
was a strong trend for an increase in plasma IL-1ra concentra-
tion. The plasma IL-6 response was reduced following IMT,
whereas the plasma IL-1 response was unchanged. We also
established that diaphragm fatigue and a systemic marker of
oxidative stress were not related to the increase in plasma
cytokine concentrations. Finally, a dose-response relationship
exists between respiratory muscle work and V˙ E and increases
in plasma IL-6 concentration.
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